View in EDS

Author response: Prospective validation of the PML risk biomarker l-selectin and influence of natalizumab extended intervals.

Saved in:
Bibliographic Details
Title: Author response: Prospective validation of the PML risk biomarker l-selectin and influence of natalizumab extended intervals.
Authors: Schwab N; (Muenster, Germany)., Schneider-Hohendorf T; (Muenster, Germany)., Pignolet B; (Toulouse, France)., Brassat D; (Toulouse, France)., Wiendl H; (Muenster, Germany).
Source: Neurology [Neurology] 2020 Sep 15; Vol. 95 (11), pp. 505.
Publication Type: Journal Article; Comment
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print Cited Medium: Internet ISSN: 1526-632X (Electronic) Linking ISSN: 00283878 NLM ISO Abbreviation: Neurology Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32934158
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Author response: Prospective validation of the PML risk biomarker l-selectin and influence of natalizumab extended intervals.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Schwab+N%22">Schwab N</searchLink>; (Muenster, Germany).<br /><searchLink fieldCode="AU" term="%22Schneider-Hohendorf+T%22">Schneider-Hohendorf T</searchLink>; (Muenster, Germany).<br /><searchLink fieldCode="AU" term="%22Pignolet+B%22">Pignolet B</searchLink>; (Toulouse, France).<br /><searchLink fieldCode="AU" term="%22Brassat+D%22">Brassat D</searchLink>; (Toulouse, France).<br /><searchLink fieldCode="AU" term="%22Wiendl+H%22">Wiendl H</searchLink>; (Muenster, Germany).
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220401060%22">Neurology</searchLink> [Neurology] 2020 Sep 15; Vol. 95 (11), pp. 505.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Comment
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lippincott+Williams+%26+Wilkins%22">Lippincott Williams & Wilkins </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0401060 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1526-632X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200283878%22">00283878 </searchLink><i>NLM ISO Abbreviation: </i>Neurology <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32934158
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1212/WNL.0000000000010513
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 505
    Titles:
      – TitleFull: Author response: Prospective validation of the PML risk biomarker l-selectin and influence of natalizumab extended intervals.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Schwab N
      – PersonEntity:
          Name:
            NameFull: Schneider-Hohendorf T
      – PersonEntity:
          Name:
            NameFull: Pignolet B
      – PersonEntity:
          Name:
            NameFull: Brassat D
      – PersonEntity:
          Name:
            NameFull: Wiendl H
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 09
              Text: 2020 Sep 15
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1526-632X
          Numbering:
            – Type: volume
              Value: 95
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Neurology
              Type: main
ResultId 1